16 mai 2018 - FDA approved Lucemyra (lofexidine hydrochloride), the first non-opioid treatment for the mitigation of withdrawal symptoms associated with abrupt discontinuation of opioids.
Ajouté au bande de temps:
Date:
16 mai 2018
Maintenaint
~ Il y a 7 ans et 5 mois